We investigated the mechanism of EDHF mediated dilation to bradykinin (BK) in piglet pial arteries. Topically applied BK (3 µmol/L) induced vasodilation (62±12%) after the administration of L-NAME and indomethacin, which was inhibited by endothelial impairment or by the BK 2 receptor antagonist HOE-140 (0.3 µmol/L). 
Introduction
There is considerable evidence showing that bradykinin (BK) is a mediator of pathophysiological reactions such as inflammation and edema formation (22, 46) . All parts of the kininogen system have been described in the cerebral circulation (54) , and kinins have been extensively studied for their implications in the transmission of nociceptive information (34) and the control of blood pressure (9, 35) . In the central nervous system, BK is found to be the main mediator of edema formation (46, 47, 55) , and it is also a potent dilator of arteries (36, 41, 54, 58 ). However, the mechanisms which contribute to BK-induced cerebral vasodilation are not well understood (54) .
The actions of BK are mediated via specific G-protein coupled receptors, of which two different types have been identified so far. The BK 1 receptor is located mainly on neurons (44) and can also be found on the surface of adventitial fibroblasts of cerebral arteries (51) . BK 2 receptors are represented in all layers of the cerebral vessel wall; their presence has been documented in cerebral endothelial as well as smooth muscle and adventitial cells (16, 44, 51, 53) . In a variety of preparations the vasodilator effect of BK is abolished by removal of the endothelium and is mediated by the BK 2 receptor subtype (54) .
Vasorelaxation to BK is mediated in part by nitric oxide (NO) formation (6, 21, 27, 30, 41) and dilator prostanoids (8, 28, 41) . Furthermore, BK is a widely used agent for evoking the release of the hypothetical endothelium derived hyperpolarizing factor (EDHF) in different regions (12, 14, 24) . Hyperpolarization induced by opening of the Ca 2+ -dependent K + -channels (K Ca ) is characteristic of EDHF (7, 12, 50, 56) , however, EDHF-like actions can be mediated via ATP-dependent K + -channels (K ATP ) also (13, 40, 56) . Arachidonic acid metabolites through the cytochrome P450 (19) or the lipoxygenase pathways acting via K Ca channels are widely accepted candidates for EDHF (40, 56) .
However, recent studies indicated that endothelial-derived hydrogen peroxide can also dilate arteries in an EDHF-like fashion.
The involvement of EDHF in agonist-induced cerebral vasodilation is not well understood. In isolated rat middle cerebral arteries, intraluminal application of uridine-5'-triphosphate induces vasodilation, which is mediated in part by EDHF (37, 62). In the same artery, BK is a potent vasodilator and its effect is still pronounced even after the blockade of the cyclooxygenase (COX) and guanylyl cyclase enzymes [Z. Benyó, Z.
Lacza and M. Wahl, unpublished observations]. However, evaluation of the contribution of EDHF to BK-induced cerebral vasodilation has not been undertaken yet.
The aim of the present study was to characterize the vasodilation induced by topical application of BK in the porcine cerebral circulation in vivo. To exclude the participation of the NO and prostanoid pathways, all experiments were carried out in the presence of N ω -nitro-L-arginine methyl esther (L-NAME) and indomethacin. Using topical application of specific blocking agents the involvement of potassium-channels and putative EDHFs were studied in the BK-induced pial arterial dilation.
Materials and methods

Measurement of pial arterial diameter
All procedures were approved by the Animal Care and Use Committee of Wake Forest University. Newborn (1-to 7-day-old) piglets of either sex weighing 2.39±0.06 kg were anesthetized with sodium thiopental (30 mg/kg i.p.), anesthesia was maintained with α-chloralose (75 mg/kg i.v.). The right femoral artery and vein were cannulated for blood pressure recordings, blood gas sampling, and drug administration, respectively.
The piglets were intubated via a tracheotomy and artificially ventilated with room air.
The respiratory parameters were set to maintain arterial pH, pCO 2 Following the determination of baseline diameter a dose-response curve to topically applied bradykinin (0.03, 0.3, 3 and 30 µmol/L) was performed. BK was dissolved in aCSF and was given in 3 ml infusions under the window. Pial arterial diameter was monitored continuously and the peak dilation was used for further evaluation.
In another group of animals, 20 min after i.v. administration of 15 mg/kg L-NAME and 5 mg/kg indomethacin (a generous gift from Merck, Rahway, NJ) a dose-response curve to topically applied bradykinin (0.03, 0.3, 3 and 30 µmol/L) was performed. We have previously shown that these doses effectively block the respective enzymes in the experimental preparation (3, 4, 11) . Repeated application of BK after the first dose response curve had an inconsistently lower effect, therefore BK was applied only for one response (3 µM) in each L-NAME + indomethacin treated animal.
In all other experimental groups, specific inhibitors were applied topically 10 min 
Results
Topically applied BK induced dose-dependent vasodilation. The dilation to each dose was transient, reached its peak within 1 min and returned to baseline within 3 min.
Administration of aCSF alone did not change vascular diameter. Systemic application of L-NAME and indomethacin increased blood pressure (from 68±2 mmHg to 93±3 mmHg, p<0.01) and significantly constricted pial arteries (from 107±2 µm to 87±3 µm, p<0.01).
The dilator response of BK was significantly shifted to lower diameter values due to the constricted initial diameter in the presence of L-NAME and indomethacin (Fig. 1 ).
There was no significant difference in baseline vascular diameter values among the experimental groups. None of the applied additional treatments (HOE-140, baicalein, CDC, catalase, miconazole) affected baseline arterial diameter or smooth muscle responsiveness to SNP (data not shown).
The remaining substantial dilation to BK (62±12%) following L-NAME and indomethacin was completely inhibited by the application of the selective BK 2 receptor antagonist HOE-140 (54±11 µm versus 3±2 µm increase in vessel diameter, p<0.01) (Fig.2) . Furthermore, endothelial impairment by intracarotid application of PDB markedly decreased the BK-response (54±11 µm versus 16±6 µm increase in vessel diameter, p<0.05) (Fig. 2) .
Western blotting experiments using a monoclonal antibody against the BK 2 receptor showed a double immunoreactive band at 42 kDa in both brain cortex and pial vascular tissue samples (Fig. 3) . The bands were doublets in case of the samples and the companyprovided standards as well, probably representing two slightly different splice-variants of the BK 2 receptor (48).
The cytochrome P450 antagonist miconazole, as well as the lipoxygenase inhibitors baicalein and CDC had no effect on BK induced dilation. In contrast, the H 2 O 2 scavenger catalase abolished the BK reponse (54±11 µm versus 0±2 µm increase in vessel diameter, p<0.01) (Fig.4) . 
Discussion
In the present study we have shown that BK is a remarkably potent vasodilator in the piglet pial vasculature even after the blockade of nitric oxide synthase (NOS) and COX. This dilation is dependent on endothelium and requires the action of BK 2 receptors. The effect is mediated via H 2 O 2 formation and the opening of K ATP channels.
To the best of our knowledge, this is the first indication of the role of an EDHF in the newborn cerebral circulation.
In the present study, the specific BK 2 receptor antagonist HOE-140 abolished the vasodilation induced by BK, indicating the prominent role of this receptor subtype in the mediation of vasorelaxation to BK. A similar exclusive participation has already been described in other species like rat (21) and cat (58). The BK 1 receptor appears to have no contribution to vasorelaxation, at least in the preparations studied so far (54, 58) . BK 2 receptors were found in both neural and vascular tissue in the present study. Receptors at each location may have a role in the mediation of vasodilation, however, the BK induced response is primarily endothelium-dependent in various preparations (21, 43, 54) . In the present study, endothelium-impairment with phorbol esther markedly reduced the BKresponse. This in vivo approach of endothelial impairment has been shown to reduce endothelium-mediated vasodilation and constriction, while the smooth muscle responsiveness remained intact. Accordingly, in the present study the endothelium independent vasodilation to SNP remained intact following PDB infusion. Furthermore, in a recent study of Willis and Leffler (59) endothelial impairment with the light-dye technique also abolished the BK response, making it less likely that neural or direct smooth muscle action can account for the effect. Although endothelial denudation cannot be adequately performed in vivo, two independent approaches provided the same results.
Therefore, this substantial, non-NO, non-prostanoid mediated vasodilation appears to be the specific action of BK 2 receptors of the endothelial cell layer. Since BK induces EDHF release in different vascular beds, our next aim was to test which of the various EDHF candidates can be responsible for the observed vasodilation.
There is considerable evidence that cytochrome P450 products dilate cerebral arteries and thus act like EDHF (2, 15, 20, 32) In the present study, blocking arachidonic acid metabolism at the lipoxygenase or the cytochrome P450 pathways failed to reduce the BK-response, making it unlikely that vasodilator arachidonic acid derivates contribute to the response.
Previous in vivo observations showed that BK relaxes the pial arteries via H 2 O 2 formation in mice, rats and cats (28, 29, 45, 60) , as well as in the porcine coronaries (43) .
Furthermore, H 2 O 2 has recently been shown to fulfill the criteria to be an EDHF in mouse isolated vessels (38, 52 The dilator action of H 2 O 2 is reported to be mediated by hyperpolarization through potassium channels (23, 38, 49, 57, 61) . The main contributing channel type is dependent on the species, for example in the cat pial vasculature K ATP channels mediate the response, while in rats or dogs the K Ca -channels are responsible (25, 49, 57) . Patch clamp studies provided direct evidence that H 2 O 2 induces hyperpolarization of the cell membrane, which was inhibited by the K ATP channel blocker glibenclamide (18) . In the rat cerebral circulation the dilator effect of BK was inhibited to a similar extent by either catalase or the K Ca -channel blocker iberiotoxin (49) . In the present study, both catalase and glibenclamide markedly reduced the response to BK in the piglet pial vasculature, indicating that the H 2 O 2 induced vasodilation is mediated by K ATP -channel derived hyperpolarization. Since glibenclamide did not totally abolish the BK-induced dilation, it seems likely that other mechanisms including cyclic nucleotides also contribute to the dilator response.
In conclusion, hydrogen peroxide has been found to be an EDHF-like mediator of the BK induced vasodilation in the piglet cerebral circulation. Together with NOS and COX metabolites, EDHF appears to be an important mediator of vasodilation in the neonatal cerebral circulation. 
